Providence St. Joseph Health

Providence St. Joseph Health Digital Commons
View all

Providence Nursing Research Conference

6-2021

Improving Primary Care Screening for Familial
Hypercholesterolemia
Mary Nametka
Brenda Senger
Providence Sacred Heart, brenda.senger@providence.org

Follow this and additional works at: https://digitalcommons.psjhealth.org/prov_rn_conf_all
Part of the Cardiology Commons, and the Nursing Commons

Recommended Citation
Nametka, Mary and Senger, Brenda, "Improving Primary Care Screening for Familial
Hypercholesterolemia" (2021). View all. 6.
https://digitalcommons.psjhealth.org/prov_rn_conf_all/6

This Conference Proceeding is brought to you for free and open access by the Providence Nursing Research
Conference at Providence St. Joseph Health Digital Commons. It has been accepted for inclusion in View all by an
authorized administrator of Providence St. Joseph Health Digital Commons. For more information, please contact
digitalcommons@providence.org.

Improving Primary Care Screening for
Familial Hypercholesterolemia
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Introduction
Familial Hypercholesterolemia (FH) is the
most common genetic condition resulting in
cardiovascular disease, a leading cause of death
in the United States. An estimated 90% of
individuals with FH remain undiagnosed.

Purpose
The purpose of this quality improvement
project was to increase provider awareness and
promote screening for FH among adults ages
20 years and older by: 1) educating providers
about FH; 2) evaluating lipid screening
practices on admission and every five years; 3)
evaluating treatment status for clients
exceeding the LDL-C 190 mg/dl cut-point; and
4) evaluating program impact on lipid
screening practice.

Participants/Setting

Results

Methods
A pre/posttest quality improvement project
design with retrospective chart review assessed
provider knowledge and screening practices
documenting the proportion of patients
screened for FH. Knowledge pretest-posttest
surveys were sent by email to all clinic site
providers with a continuing education article
Laminated copies of the cholesterol
management guideline algorithms (Grundy et
al., 2019) were provided as part of the
educational program.

Discussion

Outcome measures of FH knowledge were
reported using descriptive statistics. An
independent samples t-test showed no
statistically significant change in screening
practices pre/post-intervention (p = 0.976),
with a mean interval of 2.09 years between
initial and subsequent testing. Regression
analysis yielded a medium correlation effect
between age and lipid testing intervals,
decreasing by .028 years for every one-year
increase in age.
Coefficients with Screening Interval as Dependent Variable

A retrospective chart review was conducted by
EMR database searches to compare proportions
of lipid tests recorded pre/post-education.
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The proportion of clinic patients exceeding the
expected population estimate for FH was
significant (p < .001). Return of clinical impact
survey data did not occur.

Site: an independent primary care practice with
two locations and five rotating provider staff
with a patient base of approximately 3,500
clients ages 20 years and older.

The Electronic Medical Record (EMR) based data
collection process and online education delivery
methods were a good fit for this project because
they were low-cost, non-intrusive, and did not
require participant cooperation from patients. Lipid
screening was found to be done more frequently
with increased age. Since FH increases risk from
birth, this data might prompt a screening protocol
discussion.

Conclusion
Opportunities for quality improvement have been
identified at the study site for improved awareness
and screening for FH. The prevalence of patients
at high-risk for FH has been reported. Continued
data collection, benchmarking and process
improvement efforts can help prevent the
premature morbidity and mortality associated with
familial hypercholesterolemia.
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